Global Fatty Liver Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 117 pages | ID: G6FCA4E0B1DGEN
GlobalInfoResearch

Abstracts

Fatty liver disease is one of the most common liver dysfunction where the triglyceride fat accumulates in liver cells.

SCOPE OF THE REPORT:

The major risks associated with fatty liver disease are alcoholic cirrhosis, cardiovascular disorder, metabolic syndrome and biliary cirrhosis among others.
The global Fatty Liver Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Fatty Liver Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Fatty Liver Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Fatty Liver Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers

• Cardax
• Daewoong
• Roche
• Glenmark
• GW
• Limerick BioPharma
• Merck
• Novartis
• Orchid
• AstraZeneca

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Thiazolidinedione
• Vitamin E
• Metformin Statins
• Polyunsaturated Fatty Acids
• Angiotensin Receptor Blockers
• Pentoxifylline

Market Segment by Applications, can be divided into

• Hospitals and Clinics
• Others

Contents

1 FATTY LIVER TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Fatty Liver Treatment
1.2 Classification of Fatty Liver Treatment by Types
  1.2.1 Global Fatty Liver Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Fatty Liver Treatment Revenue Market Share by Types in 2017
  1.2.3 Thiazolidinedione
  1.2.4 Vitamin E
  1.2.5 Metformin Statins
  1.2.6 Polyunsaturated Fatty Acids
  1.2.7 Angiotensin Receptor Blockers
  1.2.8 Pentoxifylline
1.3 Global Fatty Liver Treatment Market by Application
  1.3.1 Global Fatty Liver Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals and Clinics
  1.3.3 Others
1.4 Global Fatty Liver Treatment Market by Regions
  1.4.1 Global Fatty Liver Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Fatty Liver Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Fatty Liver Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Fatty Liver Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Fatty Liver Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Fatty Liver Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Fatty Liver Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Cardax
  2.1.1 Business Overview
  2.1.2 Fatty Liver Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Cardax Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Daewoong
  2.2.1 Business Overview
  2.2.2 Fatty Liver Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Daewoong Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Roche
  2.3.1 Business Overview
  2.3.2 Fatty Liver Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Roche Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Glenmark
  2.4.1 Business Overview
  2.4.2 Fatty Liver Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Glenmark Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 GW
  2.5.1 Business Overview
  2.5.2 Fatty Liver Treatment Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 GW Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Limerick BioPharma
  2.6.1 Business Overview
  2.6.2 Fatty Liver Treatment Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Limerick BioPharma Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
  2.7.1 Business Overview
  2.7.2 Fatty Liver Treatment Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Merck Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
  2.8.1 Business Overview
  2.8.2 Fatty Liver Treatment Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Novartis Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Orchid
  2.9.1 Business Overview
  2.9.2 Fatty Liver Treatment Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Orchid Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
  2.10.1 Business Overview
  2.10.2 Fatty Liver Treatment Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 AstraZeneca Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL FATTY LIVER TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Fatty Liver Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Fatty Liver Treatment Players Market Share
  3.2.2 Top 10 Fatty Liver Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL FATTY LIVER TREATMENT MARKET SIZE BY REGIONS

4.1 Global Fatty Liver Treatment Revenue and Market Share by Regions
4.2 North America Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Fatty Liver Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA FATTY LIVER TREATMENT REVENUE BY COUNTRIES

5.1 North America Fatty Liver Treatment Revenue by Countries (2013-2018)
5.2 USA Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Fatty Liver Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE FATTY LIVER TREATMENT REVENUE BY COUNTRIES

6.1 Europe Fatty Liver Treatment Revenue by Countries (2013-2018)
6.2 Germany Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
6.4 France Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Fatty Liver Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC FATTY LIVER TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Fatty Liver Treatment Revenue by Countries (2013-2018)
7.2 China Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
7.5 India Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Fatty Liver Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA FATTY LIVER TREATMENT REVENUE BY COUNTRIES

8.1 South America Fatty Liver Treatment Revenue by Countries (2013-2018)
8.2 Brazil Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Fatty Liver Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE FATTY LIVER TREATMENT BY COUNTRIES

9.1 Middle East and Africa Fatty Liver Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Fatty Liver Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL FATTY LIVER TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Fatty Liver Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Fatty Liver Treatment Market Forecast by Type (2018-2023)
10.3 Thiazolidinedione Revenue Growth Rate (2013-2023)
10.4 Vitamin E Revenue Growth Rate (2013-2023)
10.5 Metformin Statins Revenue Growth Rate (2013-2023)
10.6 Polyunsaturated Fatty Acids Revenue Growth Rate (2013-2023)
10.7 Angiotensin Receptor Blockers Revenue Growth Rate (2013-2023)
10.8 Pentoxifylline Revenue Growth Rate (2013-2023)

11 GLOBAL FATTY LIVER TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Fatty Liver Treatment Revenue Market Share by Application (2013-2018)
11.2 Fatty Liver Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals and Clinics Revenue Growth (2013-2018)
11.4 Others Revenue Growth (2013-2018)

12 GLOBAL FATTY LIVER TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Fatty Liver Treatment Market Size Forecast (2018-2023)
12.2 Global Fatty Liver Treatment Market Forecast by Regions (2018-2023)
12.3 North America Fatty Liver Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Fatty Liver Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Fatty Liver Treatment Revenue Market Forecast (2018-2023)
12.6 South America Fatty Liver Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Fatty Liver Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Fatty Liver Treatment Picture
Table Product Specifications of Fatty Liver Treatment
Table Global Fatty Liver Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Fatty Liver Treatment Revenue Market Share by Types in 2017
Figure Thiazolidinedione Picture
Figure Vitamin E Picture
Figure Metformin Statins Picture
Figure Polyunsaturated Fatty Acids Picture
Figure Angiotensin Receptor Blockers Picture
Figure Pentoxifylline Picture
Table Global Fatty Liver Treatment Revenue (Million USD) by Application (2013-2023)
Figure Fatty Liver Treatment Revenue Market Share by Applications in 2017
Figure Hospitals and Clinics Picture
Figure Others Picture
Table Global Market Fatty Liver Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Fatty Liver Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Fatty Liver Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Fatty Liver Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Fatty Liver Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Fatty Liver Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Fatty Liver Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Cardax Basic Information, Manufacturing Base and Competitors
Table Cardax Fatty Liver Treatment Type and Applications
Table Cardax Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Daewoong Basic Information, Manufacturing Base and Competitors
Table Daewoong Fatty Liver Treatment Type and Applications
Table Daewoong Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Fatty Liver Treatment Type and Applications
Table Roche Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Glenmark Basic Information, Manufacturing Base and Competitors
Table Glenmark Fatty Liver Treatment Type and Applications
Table Glenmark Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table GW Basic Information, Manufacturing Base and Competitors
Table GW Fatty Liver Treatment Type and Applications
Table GW Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Limerick BioPharma Basic Information, Manufacturing Base and Competitors
Table Limerick BioPharma Fatty Liver Treatment Type and Applications
Table Limerick BioPharma Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Fatty Liver Treatment Type and Applications
Table Merck Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Fatty Liver Treatment Type and Applications
Table Novartis Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Orchid Basic Information, Manufacturing Base and Competitors
Table Orchid Fatty Liver Treatment Type and Applications
Table Orchid Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Fatty Liver Treatment Type and Applications
Table AstraZeneca Fatty Liver Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Fatty Liver Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Fatty Liver Treatment Revenue Share by Players (2013-2018)
Figure Global Fatty Liver Treatment Revenue Share by Players in 2016
Figure Global Fatty Liver Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Fatty Liver Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Fatty Liver Treatment Revenue Market Share in 2017
Figure Global Fatty Liver Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Fatty Liver Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Fatty Liver Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Fatty Liver Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Fatty Liver Treatment Revenue Market Share by Regions in 2017
Figure North America Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure South America Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Table North America Fatty Liver Treatment Revenue by Countries (2013-2018)
Table North America Fatty Liver Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Fatty Liver Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Fatty Liver Treatment Revenue Market Share by Countries in 2017
Figure USA Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Table Europe Fatty Liver Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Fatty Liver Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Fatty Liver Treatment Revenue Market Share by Countries in 2017
Figure Germany Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure UK Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure France Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Fatty Liver Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Fatty Liver Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Fatty Liver Treatment Revenue Market Share by Countries in 2017
Figure China Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure India Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Table South America Fatty Liver Treatment Revenue by Countries (2013-2018)
Table South America Fatty Liver Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Fatty Liver Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Fatty Liver Treatment Revenue Market Share by Countries in 2017
Figure Brazil Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Fatty Liver Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Fatty Liver Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Fatty Liver Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Fatty Liver Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Fatty Liver Treatment Revenue and Growth Rate (2013-2018)
Table Global Fatty Liver Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Fatty Liver Treatment Revenue Share by Type (2013-2018)
Figure Global Fatty Liver Treatment Revenue Share by Type (2013-2018)
Figure Global Fatty Liver Treatment Revenue Share by Type in 2017
Table Global Fatty Liver Treatment Revenue Forecast by Type (2018-2023)
Figure Global Fatty Liver Treatment Market Share Forecast by Type (2018-2023)
Figure Global Thiazolidinedione Revenue Growth Rate (2013-2018)
Figure Global Vitamin E Revenue Growth Rate (2013-2018)
Figure Global Metformin Statins Revenue Growth Rate (2013-2018)
Figure Global Polyunsaturated Fatty Acids Revenue Growth Rate (2013-2018)
Figure Global Angiotensin Receptor Blockers Revenue Growth Rate (2013-2018)
Figure Global Pentoxifylline Revenue Growth Rate (2013-2018)
Table Global Fatty Liver Treatment Revenue by Application (2013-2018)
Table Global Fatty Liver Treatment Revenue Share by Application (2013-2018)
Figure Global Fatty Liver Treatment Revenue Share by Application (2013-2018)
Figure Global Fatty Liver Treatment Revenue Share by Application in 2017
Table Global Fatty Liver Treatment Revenue Forecast by Application (2018-2023)
Figure Global Fatty Liver Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospitals and Clinics Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Fatty Liver Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Fatty Liver Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Fatty Liver Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Fatty Liver Treatment Revenue Market Forecast (2018-2023)
Figure Europe Fatty Liver Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Fatty Liver Treatment Revenue Market Forecast (2018-2023)
Figure South America Fatty Liver Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Fatty Liver Treatment Revenue Market Forecast (2018-2023)